Company Description
Diversified Healthcare Trust is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States.
DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location.
As of March 31, 2026, DHC’s approximately 6.2 billion dollars portfolio included 285 properties in 33 states and Washington, D.C., with 23,901 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 250 tenants.
DHC is managed by The RMR Group, a leading U.S. alternative asset management company with over 37 billion dollars in assets under management as of March 31, 2026 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate.
DHC is headquarters in Newton, MA. Diversified Healthcare Trust was incorporated in 1998 in Maryland.
| Country | United States |
| Founded | 1998 |
| Industry | REIT - Healthcare Facilities |
| Sector | Real Estate |
| Employees | 600 |
| CEO | Christopher Bilotto |
Contact Details
Address: Two Newton Place, 255 Washington Street, Suite 300 Newton, Massachusetts 02458-1634 United States | |
| Phone | 617 796 8350 |
| Website | dhcreit.com |
Stock Details
| Ticker Symbol | DHC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1075415 |
| CUSIP Number | 25525P107 |
| ISIN Number | US25525P1075 |
| Employer ID | 04-3445278 |
| SIC Code | 6798 |
Key Executives
| Name | Position |
|---|---|
| Christopher J. Bilotto | President, Chief Executive Officer and Managing Trustee |
| Adam David Portnoy | Managing Chair of the Board |
| Matthew C. Brown CPA | Chief Financial Officer and Treasurer |
| Matt Murphy | Manager of Investor Relations |
| David M. Blackman | Director of Acquisition |
| Lindsey A. Getz J.D. | Secretary |
| Anthony Paula | Vice President |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 12, 2026 | 8-K | Current Report |
| Jun 1, 2026 | 8-K | Current Report |
| May 5, 2026 | 8-K | Current Report |
| May 4, 2026 | 10-Q | Quarterly Report |
| May 4, 2026 | 8-K | Current Report |
| Mar 26, 2026 | SCHEDULE 13G/A | Filing |
| Mar 25, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 19, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 19, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 19, 2026 | ARS | Filing |